ArticleFrontiers in immunology2026

Timing and intensity of proton pump inhibitor exposure hampers overall survival in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors: a retrospective cohort study.

Nuša Japelj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.